Skip to Main content Skip to Navigation
Journal articles

PET imaging in patients with brain metastasis—report of the RANO/PET group

Abstract : Brain metastases (BM) from extracranial cancer are associated with significant morbidity and mortality. Effective local treatment options are stereotactic radiotherapy, including radiosurgery or fractionated external beam radiotherapy, and surgical resection. The use of systemic treatment for intracranial disease control also is improving. BM diagnosis, treatment planning, and follow-up is most often based on contrast-enhanced magnetic resonance imaging (MRI). However, anatomic imaging modalities including standard MRI have limitations in accurately characterizing posttherapeutic reactive changes and treatment response. Molecular imaging techniques such as positron emission tomography (PET) characterize specific metabolic and cellular features of metastases, potentially providing clinically relevant information supplementing anatomic MRI. Here, the Response Assessment in Neuro-Oncology working group provides recommendations for the use of PET imaging in the clinical management of patients with BM based on evidence from studies validated by histology and/or clinical outcome.
Document type :
Journal articles
Complete list of metadata
Contributor : Michel SALZET Connect in order to contact the contributor
Submitted on : Thursday, September 17, 2020 - 10:16:18 AM
Last modification on : Wednesday, August 24, 2022 - 4:26:31 PM

Links full text




Norbert Galldiks, Karl-Josef Langen, Nathalie Albert, Marc Chamberlain, Riccardo Soffietti, et al.. PET imaging in patients with brain metastasis—report of the RANO/PET group. Neuro-Oncology, Oxford University Press (OUP), 2019, 21 (5), pp.585-595. ⟨10.1093/neuonc/noz003⟩. ⟨inserm-02941535⟩



Record views